Fresenius Kabi

Malnutrition is a serious threat that impacts patients' recovery, quality of life, and treatment outcomes. Yet, day by day, healthcare professionals around the world work tirelessly to turn the tide. We would like to say “thank you” to all healthcare professionals who work passionately to deliver life-sustaining treatments, helping to ensure that patients have a solid foundation for health, with nutrition being a vital part of it. Every day, your work makes a real difference in the lives of patients, supporting their treatment and recovery. 💙 At Fresenius Kabi, we are committed to supporting your passion in the fight against malnutrition. Together we make a real difference! 🤝 We also support research and advancements in this field through our international programs like the JUMPstart Clinical Nutrition Program, special grants such as the LAM Research Grant and the ESICM-Fresenius Kabi Clinical Nutrition Research Award, as well as global initiatives like United for Clinical Nutrition (UFCN). #ESPENMAW2024 #NutritionMatters #MedicalNutrition #CommittedToLife

So proud that Fresenius Kabi has received the 2024 Novaplus Program Excellence Award from Vizient, recognizing our commitment to superior service, reliability, and integrity. This award is truly a testament to the dedication of our teams across the U.S. and globally. Over the past year, we delivered high-quality pharmaceutical solutions that support Vizient members and their patients. Special thanks to our incredible teams at Fresenius Kabi USA for achieving this milestone. Together, we are #CommittedToLife. #FreseniusKabi #FutureFresenius #Vizient #Novaplus 

We now have four biosimilars approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), expanding access to high-quality treatments for patients across the globe. Fresenius Kabi’s growing pipeline of autoimmune and oncology biosimilars also has several molecules in early and late-stage development. ❓ Wondering how biosimilars can make a difference? Biosimilars are paving the way for a more accessible, affordable healthcare future by: 🔹 Lowering costs for patients and healthcare systems 🔹 Expanding access to treatments 🔹 Increasing high-quality treatment options for patients and healthcare providers Biosimilars enable more patients to gain access to the care they need! #GlobalBiosimilarsWeek #Biosimilars #FutureFresenius #CommittedToLife

Altogether, up to 33 million patients struggle with malnutrition every year, at an annual cost of €170 billion in Europe alone. It affects one in three patients in care homes and nearly a quarter of those in hospitals. This Malnutrition Awareness Week is a vivid reminder of the millions who face related health challenges and the critical importance of nutrition for recovery and resilience overall. And malnutrition is not limited to any one region or age group. It potentially affects everyone. Behind these numbers are individuals whose recovery, dignity, and quality of life depend on accessible nutritional support. When people don’t receive the nutrients they need, healing can slow down, leading to longer recovery times and even setbacks. This doesn't just impact individuals – it places a significant strain on healthcare systems. At Fresenius Kabi, we are committed to play a decisive role in making state-of-the-art clinical nutrition accessible. And clinical nutrition is truly driven by continuous innovation that improves the treatment outcome of critically and chronically ill patients. It’s all about placing patients at the heart of care and giving them the chance to regain strength, resilience, and independence. #FreseniusKabi #FutureFresenius #CommittedToLife #MalnutritionAwarenessWeek

We proceed on our #Biopharma platform in line with #FutureFresenius: mAbxience, a Fresenius Kabi majority-owned group, and Egis Pharmaceuticals PLC have entered a strategic commercialization agreement for two biosimilar candidates in key Central and Eastern European markets. This is great news and underlines our shared commitment to making high-quality, life-saving treatments accessible in global healthcare. #CommittedToLife

☝️ Malnutrition affects more people than you think! Malnutrition is a serious threat to health, and here are just a few examples: - 1 in 4 hospital patients suffer from malnutrition. - 1 in 5 children in hospitals affected. - For cancer patients, 1 in 3 are malnourished. Medical nutrition is at the heart of patient care, especially for those who cannot rely on traditional eating methods. Malnutrition does significantly impact recovery and treatment outcomes. With a complete range, from enteral nutrition through oral supplementation or feeding tubes to parenteral nutrition administered directly into the bloodstream, these interventions provide the essential nutrients needed to support healing, recovery, and resilience of patients. Our aim is to improve nutritional status and support therapy outcomes of patients. Together, let's nourish bodies and fight malnutrition wherever we encounter it. 🤝 #ESPENMAW2024 #NutritionMatters #MedicalNutrition #CommittedToLife

Meet Camila Hernández Losada, a dynamic Communication & Digital Specialist at Fresenius Kabi in Colombia.✨ Camila’s day kicks off with a delicious Frappuccino made from rich Colombian coffee, which she enjoys while catching up with her colleagues. For her, it’s the perfect moment to connect before diving into her tasks.☕ “I love starting my day with a friendly chat and a coffee – it helps me focus and sets the tone for the day ahead,” she shares. Her workday is a mix of creativity and strategy. Whether she is checking social media content to ensure it reflects our values, analyzing KPIs to refine and improve future campaigns, or organizing product shoots to capture the essence of our brand, Camila is dedicated to living our Fresenius principle "We Care for Excellence." She collaborates closely with colleagues to refine messaging and is constantly seeking for innovative ways to make Fresenius' message stand out and resonate.🎯 "I thrive on the chance to innovate and push the boundaries of what we can achieve as a company," Camila explains. "Every day is different, and that’s what makes it exciting." Having joined Fresenius Kabi in 2019, after working as a community manager at an ad agency, Camila quickly realized this was the place where she could grow both personally and professionally. "Fresenius Kabi truly lives its principles, and the people here are passionate about making a difference. That’s what makes it special," she says. For Camila, Fresenius’ #CommittedToLife promise is at the heart of everything she does. “Knowing that our work helps improve people’s lives gives me purpose. It’s the small, everyday actions that make the biggest impact.” #TeamFresenius

Fresenius Group has just published the Q3 results. Continuing on our transformative pathway in line with #Vision2026, Fresenius Kabi keeps delivering across its Business Units #Biopharma, #MedTech, #Nutrition, and #Pharma, impacting almost 450 million patients annually. Read more from our CEO Pierluigi Antonelli:

Supporting healthy growth in young patients: Trace elements are needed in tiny amounts, but they are mighty nutrients essential in pediatric parenteral nutrition. They play a key role for fostering optimal growth, development, and the overall health of children. 👶 Are you interested in understanding the impact of trace elements on child health and the latest research findings? 👉 Explore the significance of these important nutrients and their adequate dosing according to international guidelines at https://lnkd.in/ePBzuS9w . #Pediatrics #ParenteralNutrition #CommittedToLife

As we conclude our Breast Cancer Awareness Month series, we want to highlight the incredible work of our Women’s VOICE Employee Impact Group (EIG) in the U.S. This group is committed to fostering a supportive community where women and allies work together to create an inclusive culture for all and a space for women to grow, connect, and thrive – both personally and professionally. Through initiatives like mentorship programs, leadership development, and health-focused campaigns, the Women’s VOICE EIG has made a lasting impact. Each October, they lead an active campaign to raise awareness about breast cancer, encouraging early detection and prevention. Tanya Tyska, Senior Director Internal Communications, co-chair of the group, shares: “Early detection of breast cancer made an important difference in my life. Today, I’m a healthy, active mother of two with a fulfilling career. I am grateful for every day, and want to inspire other women to prioritize their health for themselves and their loved ones.” Her co-chair, Bela Bhandari, Senior Director Marketing, adds: “We’re creating a space where women and allies can thrive. Raising awareness about breast cancer is one of many ways we’re supporting women in making their health a priority.” With over 250 members, the Women’s VOICE EIG continues to make a powerful difference, aligning with the Fresenius promise of #CommittedToLife. #BreastCancerAwareness #TeamFresenius